EGFR and head and neck squamous cell carcinoma: Moreover, animal experiments, either by implanting PIK3C2A downregulated tumors or by using PI3K‐C2α specific inhibitors, are warranted to determine whether PI3K‐C2α inhibition can sensitize resistant HNSCC tumors to EGFR inhibition.